U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07668765) titled 'GLP-1 Receptor Agonists and Early Proctologic Effects in Morbid Obesity' on June 04.
Brief Summary: Prospective observational cohort study evaluating the early proctologic effects of GLP-1 receptor agonist therapy in morbidly obese patients. Participants will undergo baseline and 3-month anorectal symptom assessment and proctologic examination to evaluate newly developed proctologic diseases and changes in pre-existing symptoms.
Study Start Date: Aug., 2026
Study Type: OBSERVATIONAL
Condition:
Morbid Obesity
Anorectal Diseases
Drug-Related Side Effects and Adverse Reactions
Constipation
Diarrhea
Intervention:
DRUG: GLP-1 recep...